Active substances
Guaifenesin + Pseudoephedrine + Triprolidine
- SFDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| RINOFED EXPECTORANT SYRUP 100 ML | 20,6,0.25 mg/ml,mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 7.30 | Generic · OTC | Jazeera Pharmaceutical Industries (JPI) | Valid |
| TRIPOFED EXPECTORANT SYRUP | 20,6,0.25 mg/ml,mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 7.30 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| ACTIFED EXPECTORANT SYRUP | 0.25, 6, 20 mg/ml | Syrup · Oral use | 1 Bottle | SAR 6.60 | Generic · OTC | GLAXO SAUDI ARABIA | Withdrawn by MAH · Not Marketed |
| PECTOMED EXPECTORANT SYRUP | 20,6,0.25 mg/ml,mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 5.50 | Generic · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| UNIFED EXPECTORANT SYRUP | 20,6,0.25 mg/ml,mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 5.10 | Generic · OTC | UNITED PHARMACEUTICAL CO. | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.